Drug Information Association Logo

Quantitative Science Forum

Oct 31 2014 9:00AM - Nov 1 2014 5:00PM | Xinjiang Plaza Attn: Miss Ying Zhao No. 7 Sanlihe Road 100027 Beijing China

« Back to Listing


The first DIA “quantitative science forum” in 2013 was a successful event that provided a multi-functional forum within China to discuss quantitative science topics in pharmaceutical product development. DIA and China Clinical Trial Statistics (CCTS) Working Group will hold the second “quantitative science forum” in 2014. With an emerging need to evaluate drug both in pre-licensing and post licensing settings, there is no clear local guidance and consensus how to do it scientifically and operationally. Therefore, the 2014 forum is set to share knowledge and discuss quantitative issues in safety, efficacy, riskbenefit, and potentially cost-effective utilization. We will also have dedicated session featuring consensus papers from the key statistics opinion leaders and exports from CCTS.

Featured Topics 

  • Post-marketing safety (re-)evaluation: surveillance or study?
  • Statistical issues in oncology drug development
  • Statistical review and ADaM implementation
  • Vaccine effectiveness in real world: experiences and challenges
  • Big data and clinical trials and pragmatic clinical trials
  • Quantitative evaluation on risk benefit
  • Bayesian methods and applications in drug development
  • Meta-analysis: theory, application and caveats
  • Subgroup analysis
  • Issues on developing biosimilar products
  • Observation studies and health economical evaluation on medical products
  • Selected topics with consensus by domestic experts

Who Should Attend 

  • Statisticians
  • Clinicians
  • Data Management Professionals
  • Regulatory Scientists
  • Quantitative and Clinical Scientists in Academia
  • Quantitative and Clinical Scientists in Regulatory Agencies

Learning Objectives 

  • Highlight quantitative science’s critical role in medical product evaluation in clinical trials and in real world
  • Discuss different ways to evaluate pharmaceutical products from multiple angles in in the regulatory environment
  • Discuss the importance of guidance, standards, and scientific validity in medical product development

Contact Information 

For general inquiries and registration, contact
Mr. Fei XIE
Phone +86.10.6260.2240
fei.xie@diachina.org or dia@diachina.org

To Register, click here.

Registration Fees 

Other Fees



Charitable Nonprofit/Academia Member
Member Government
Member Standard


Charitable Nonprofit/Academia Nonmember
NonMember Government
NonMember Standard
Register Online
« Back to Listing Back To Top